Cerus (CERS) Gross Margin Growth (5y) (2015 - 2026)
Cerus (CERS) Gross Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.54 Bn | 176.24 Bn | 6.27 Bn |
| 2 | Stryker | 129.03 Bn | 126.15 Bn | 3.81 Bn |
| 3 | Medtronic | 108.43 Bn | 99.21 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.74 Bn | 67.28 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn |
| 6 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.78 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn |
| 10 | Cerus | 600.87 Mn | 520.44 Mn | 27.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,679.00 |
| Dec 31, 2025 | -802.00 |
| Sep 30, 2025 | 145,523.00 |
| Jun 30, 2025 | -422,357.00 |
| Mar 31, 2025 | 260,848.00 |
| Dec 31, 2024 | 13,421.00 |
| Sep 30, 2024 | -104,623.00 |
| Jun 30, 2024 | 12,231.00 |
| Mar 31, 2024 | 14,072.00 |
| Dec 31, 2023 | 3,987.00 |
| Sep 30, 2023 | -1.02 Mn |
| Jun 30, 2023 | 14,568.00 |
| Mar 31, 2023 | -4,353.00 |
| Dec 31, 2022 | 4,578.00 |
| Sep 30, 2022 | -21,128.00 |
| Jun 30, 2022 | -25,793.00 |
| Mar 31, 2022 | -6,939.00 |
| Dec 31, 2021 | 3,833.00 |
| Sep 30, 2021 | -24,093.00 |
| Jun 30, 2021 | -5,083.00 |